Ember Therapeutics

Ember Therapeutics

Ember Therapeutics

Ember Therapeutics develops the power of brown fat biology and insulinsensitization to develop treatments for metabolic diseases.
Founded
2011
Raised
$34M
Follow us
Alexa global traffic share
Latest funding
$34,000,000
Venture capital (Series A) - 2011
Third Rock Ventures
Team Size
10+
Employees
PE HUB

Ember Therapeutics to divest OP-1 product family and related assets to Viscogliosi Brothers